UPDATED Mar 27, 2024
Most Popular Stocks on the market
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$421.43 | -0.9% | 50.2% | US$3.1t | US$467.16 | PE37.9x | E12.6% | 0.7% | Software | ||
AAPL | US$173.31 | -3.0% | 7.8% | US$2.7t | US$200.53 | PE26.5x | E4.8% | 0.6% | Tech | ||
NVDA | US$902.50 | -0.1% | 234.5% | US$2.2t | US$955.60 | PE74.6x | E22.8% | 0.02% | Semiconductors | ||
GOOGL | US$150.87 | 1.4% | 48.8% | US$1.9t | US$164.59 | PE25.4x | E11.8% | n/a | Media | ||
AMZN | US$179.83 | 0.9% | 79.4% | US$1.9t | US$206.32 | PE61.4x | E22.0% | n/a | Retail | ||
META | US$493.86 | -2.3% | 140.5% | US$1.3t | US$524.03 | PE32.2x | E14.3% | 0.4% | Media | ||
BRK.A | US$629,610.00 | 0.2% | 36.2% | US$901.5b | US$653,333.33 | PE9.4x | E-49.1% | n/a | Diversified Financials | ||
LLY | US$778.18 | 0.7% | 131.7% | US$701.0b | US$797.44 | PE133.8x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
AVGO | US$1,318.73 | -2.2% | 108.1% | US$611.2b | US$1,497.90 | PE52.8x | E23.4% | 1.6% | Semiconductors | ||
JPM | US$199.52 | 1.6% | 54.5% | US$574.7b | US$197.03 | PB1.9x | E-1.7% | 2.3% | Banks | ||
TSLA | US$179.83 | 2.4% | -7.2% | US$572.7b | US$197.77 | PE38.2x | E9.9% | n/a | Automobiles | ||
V | US$279.02 | -3.5% | 25.0% | US$560.5b | US$301.32 | PE31.7x | E9.8% | 0.7% | Diversified Financials | ||
WMT | US$60.17 | -2.1% | 23.9% | US$489.3b | US$65.13 | PE31.3x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$114.97 | 1.8% | 5.5% | US$456.2b | US$124.23 | PE12.7x | E-1.3% | 3.3% | Energy | ||
UNH | US$493.10 | -0.2% | 5.7% | US$454.6b | US$589.45 | PE20.3x | E9.6% | 1.5% | Healthcare | ||
MA | US$477.95 | -2.1% | 32.9% | US$445.9b | US$508.98 | PE39.8x | E12.1% | 0.6% | Diversified Financials | ||
PG | US$162.61 | 0.4% | 10.8% | US$382.6b | US$169.11 | PE26.4x | E7.3% | 2.3% | Household | ||
HD | US$385.89 | 0.4% | 36.2% | US$382.4b | US$378.45 | PE25.3x | E4.1% | 2.3% | Retail | ||
JNJ | US$157.96 | 1.4% | 3.0% | US$380.6b | US$175.25 | PE28.6x | E9.1% | 3.0% | Pharmaceuticals & Biotech | ||
ORCL | US$125.27 | -3.1% | 38.2% | US$344.3b | US$137.02 | PE32.4x | E14.9% | 1.3% | Software | ||
MRK | US$131.75 | 6.4% | 25.6% | US$333.7b | US$136.01 | PE914.2x | E25.2% | 2.3% | Pharmaceuticals & Biotech | ||
COST | US$732.08 | -1.2% | 49.1% | US$324.7b | US$758.77 | PE47.8x | E7.4% | 0.6% | Consumer Retailing | ||
ABBV | US$180.35 | 2.3% | 14.1% | US$319.3b | US$183.88 | PE66.3x | E23.1% | 3.4% | Pharmaceuticals & Biotech | ||
BAC | US$37.81 | 2.9% | 31.9% | US$298.3b | US$37.54 | PB1.1x | E3.6% | 2.5% | Banks |